Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma.
Caccese M, Desideri I, Villani V, Simonelli M, Buglione M, Chiesa S, Franceschi E, Gaviani P, Stasi I, Caserta C, Brugnara S, Lolli I, Bennicelli E, Bini P, Cuccu AS, Scoccianti S, Padovan M, Gori S, Bonetti A, Giordano P, Pellerino A, Gregucci F, Riva N, Cinieri S, Internò V, Santoni M, Pernice G, Dealis C, Stievano L, Paiar F, Magni G, De Salvo GL, Zagonel V, Lombardi G. Caccese M, et al. Among authors: padovan m. ESMO Open. 2024 Apr;9(4):102943. doi: 10.1016/j.esmoop.2024.102943. Epub 2024 Mar 15. ESMO Open. 2024. PMID: 38492275 Free PMC article.
Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155).
Caccese M, Ceccato F, Fassan M, Fassina A, Padovan M, Mammi I, Iacobone M, Scaroni C, Zagonel V, Lombardi G. Caccese M, et al. Among authors: padovan m. Semin Oncol. 2019 Feb;46(1):104-105. doi: 10.1053/j.seminoncol.2018.12.005. Epub 2019 Jan 2. Semin Oncol. 2019. PMID: 30655020 No abstract available.
Corneal side effects induced by EGFR-inhibitor antibody-drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study.
Parrozzani R, Lombardi G, Midena E, Leonardi F, Londei D, Padovan M, Caccese M, Marchione G, Bini S, Zagonel V, Frizziero L. Parrozzani R, et al. Among authors: padovan m. Ther Adv Med Oncol. 2020 May 27;12:1758835920907543. doi: 10.1177/1758835920907543. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32550861 Free PMC article.
Anaplastic Astrocytoma: State of the art and future directions.
Caccese M, Padovan M, D'Avella D, Chioffi F, Gardiman MP, Berti F, Busato F, Bellu L, Bergo E, Zoccarato M, Fassan M, Zagonel V, Lombardi G. Caccese M, et al. Among authors: padovan m. Crit Rev Oncol Hematol. 2020 Sep;153:103062. doi: 10.1016/j.critrevonc.2020.103062. Epub 2020 Jul 17. Crit Rev Oncol Hematol. 2020. PMID: 32717623 Review.
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study.
Lombardi G, Barresi V, Indraccolo S, Simbolo M, Fassan M, Mandruzzato S, Simonelli M, Caccese M, Pizzi M, Fassina A, Padovan M, Masetto E, Gardiman MP, Bonavina MG, Caffo M, Persico P, Chioffi F, Denaro L, Dei Tos AP, Scarpa A, Zagonel V. Lombardi G, et al. Among authors: padovan m. Cancers (Basel). 2020 Aug 14;12(8):2283. doi: 10.3390/cancers12082283. Cancers (Basel). 2020. PMID: 32823925 Free PMC article.
132 results